PositiveID gets FDA clearance for iglucose technology

11/16/2011 | Health Data Management

The FDA has given PositiveID Corp. 510(k) clearance for its iglucose technology designed for patients with diabetes. The device enables patients to transmit blood glucose readings from a data-cable glucometer to a Web portal, where they can transmit information to family members and health care providers.

View Full Article in:

Health Data Management

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL